AD

경도인지장애와 치매, 알츠하이머병 치료기

저 분은 누구를 기다리시 나

Bronchitis, COPD, and pneumonia after viral endemic of patients with leprosy on Sorok Island in South Korea - Naunyn-Schmiedeberg's Archives of PharmacologyViral respiratory diseases (VRDs) cause lung inflammation and inflammatory cytokine production. We study whether dapsone is responsible for its observed preventive treatment effects of the sustained viral RNA interferon response. Around 2008 and 2012, Korea’s Dementia Management Act stipulated drastic changes in the administration of dementia medication by medical staff. Participants were randomized and we compared leprosy patients with VRDs after prescribing dapsone as a standard treatment from 2005 to 2019. Significance was evaluated based on the dapsone-prescribed (+) subgroup and the dapsone-unprescribed (−) subgroup of the VRD diagnosed (+) and VRD undiagnosed (−) subgroup. We analyzed VRD ( +)/(− with dapsone (+)/(−) group and used a T-test, and designed the equation of acetylation with dapsone and acetylcholine (AA) equation. The 6394 VRD participants who received the dapsone intervention compared to the 3255 VRD participants in the control group demonstrated at T2 VRD (+) dapsone (−) (mean (M) = 224.80, SD = 97.50): T3 VRD (−) dapsone (+) (M = 110.87, SD = 103.80), proving that VRD is low when dapsone is taken and high when it is not taken. The t value is 3.10, and the p value is 0.004395 (significant at p < 0.05). After an increase in VRDs peaked in 2009, bronchitis, COPD, and pneumonia surged in 2013. The AA equation was strongly negatively correlated with the prevalence of bronchitis and chronic obstructive pulmonary disease (COPD): with bronchitis, r(15) = −0.823189, p = 0.005519, and with COPD, r(15) = −0.8161, p = 0.000207 (significant at p < 0.05). Dapsone treated both bronchitis and COPD. This study provides theoretical clinical data to limit acetylcholine excess during the VRD pandemic for bronchitis, COPD, and pneumonia.

치매관리법과 과학

이종훈. 경도인지장애와 치매, 알츠하이머병 치료기. INFOMEDPRESS, 2022. https://books.google.co.kr/books?id=m3ZjEAAAQBAJ.

답손 치료는 알츠하이머병에서 발생하는 인터페론 과다 생산을 억제하는 항촉매 반응을 사용합니다: 연구논문발표 Infomed Press. INFOMEDPRESS, 2022. https://books.google.co.kr/books?id=yeJwEAAAQBAJ.

환자 진료에 대한 문의는 다음의 메일로 문의 하세요.

gooddoctor@heritage.re.kr

답손 복용 및 부작용 관리 지침 https://osf.io/9c7wz/

Protocol for SARS-CoV-2 ARDS.pdf

치매증상개선제와 사망자수 증감 발표

The listed, delisted, and sustainability of therapeutic medicines for dementia patients: the study is specific to South Korea - Naunyn-Schmiedeberg's Archives of PharmacologyThe Dementia Management Act (DMA) came into effect on August 4, 2011, in South Korea. Diagnosis and medication were rapidly performed for dementia in a short time. We investigated the cardiac effects of increased drug prescription following DMA. We observed a correlation between Alzheimer’s disease (AD) and anti-AD drug (AAD) groups from 2010 to 2019 on the National Health Insurance System (NHIS) of South Korea. This study investigated the increase and decrease in deaths of AD patients with AAD. We analysed the mortality per 100,000 population with the R2 Calculator. Moreover, we made the up or down datum line for the simple decision on the listed, delisted, and sustainable drug examined by a linear equation and R2. We observed that life expectancy was diminished by AAD in Sorokdo National Hospital. In the NHIS, donepezil and rivastigmine increased the number of deaths decided on R2 > 0.75. Memantine was sustainable. We could not decide on galantamine because it is one of the other groups. We made a straightforward decision-maker of delisted, listed, or sustainable criteria based on mortality and datum line.

Jong Hoon, LEE. 코로나 호흡기바이러스 2형 질병 (Covid-19) 병리 기전: 코로나 병리를 알면 쉽게 예방 및 치료된다. infomedpress, 2022. https://books.google.co.kr/books?id=Hn13EAAAQBAJ.

Jong Hoon, L.EE. 코로나 호흡기바이러스 2형 질병 (Covid-19) 치료 기전. infomedpress, 2022. https://books.google.co.kr/books?id=1E96EAAAQBAJ.

Page updated

Report abuse